Sandostatin

Novartis Pharmaceuticals Corporation🇺🇸 United States

FDA Page

Effective Date: Jul 22, 2026
Approval ID: 4e2c9856-1836-49f0-9472-4dbeeb408f39
Products: 3 registered
Version: 23

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use SANDOSTATIN INJECTION safely and effectively. See full prescribing information for SANDOSTATIN INJECTION. SANDOSTATIN (octreotide acetate) INJECTION, for subcutaneous or intravenous use Initial U.S. Approval: 1988

Quick Stats

Total Products3

Labelers2

Label Sections17

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.